PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-06-06

Date Title Company
06-Jun-2025 Pharmaris Canada to Lead Sales and Marketing for Vimy Pharma Products Across Canada ACCESS Newswire
06-Jun-2025 Viromed Medical AG plans change in the Supervisory Board and Chairman of the Supervisory Board Viromed Medical AG
06-Jun-2025 Straumann to invest in Villeret while localizing production for China in Shanghai Straumann Holding AG
06-Jun-2025 Mitolyn Reviews: Consumer Testimonials, Clinical Trials & The "Purple Peel" Mitochondrial Weight Loss Hype (Latest Clinical Update) ACCESS Newswire
06-Jun-2025 Mitolyn Safety Report: Exposing Fake Mitolyn Reviews, Misinformation & The Real Science Behind This Mitochondria Formula (June 2025) ACCESS Newswire
06-Jun-2025 EVERTIS SELECTS HONEYWELL ACLAR® TECHNOLOGY TO ENHANCE PHARMACEUTICAL PACKAGING Honeywell
06-Jun-2025 Marinomed Biotech AG announces partnership for Budesolv in Switzerland Marinomed Biotech AG
06-Jun-2025 Cercare Medical Secures Additional Regulatory Clearance in South Korea ACCESS Newswire
06-Jun-2025 Jaguar Health to Conduct Fireside Chat June 10 Regarding Company's Efforts to Further its Orphan Disease Development Programs as Part of Lytham Partners’ Spring 2025 Spotlight Series ACCESS Newswire
06-Jun-2025 Masco Group, a Global Leader in Engineering Technologies and Services Solutions for Biopharmaceutical Manufacturing, Expands Its U.S. Presence and Process Portfolio With the Acquisition of Techniserv ACCESS Newswire
06-Jun-2025 St John Ambulance launches national campaign urging workplaces to better prepare for traumatic injuries and mass casualty incidents St John Ambulance
06-Jun-2025 Positive Interim 2-Year Data from enVVeno Medical's VenoValve Pivotal Study to be Presented Today at the Society for Vascular Surgery (SVS) 2025 Vascular Annual Meeting ACCESS Newswire
06-Jun-2025 Aytu BioPharma Announces At the Market Pricing of $14.4 Million Upsized Public Offering of Common Stock ACCESS Newswire
06-Jun-2025 Aytu BioPharma Announces Exclusive Agreement with Fabre-Kramer Pharmaceuticals to Commercialize First-in-Class Antidepressant EXXUA(TM) (gepirone) Extended-Release Tablets in the United States ACCESS Newswire
06-Jun-2025 Preventing “Ozempic Face”: How the Naderi Center Combines Aesthetics and Weight Loss for Total Facial Rejuvenation ACCESS Newswire
06-Jun-2025 Angle PLC Announces Board Changes ACCESS Newswire
06-Jun-2025 Dr. Joseph Upton Joins LevyAesthetics in Bellevue, WA Reunites with Dr. Daniel Levy to Launch a Comprehensive Practice Centered on Personalized Medicine and Aesthetic Innovation ACCESS Newswire